Aortic aneurysm Medical Services in China

An aortic aneurysm is a localized, pathological dilation of the aorta—typically defined as a diameter exceeding 1.5 times the normal size—resulting from weakening of the arterial wall due to degeneration of elastin and collagen fibers. It most commonly occurs in the abdominal aorta (abdominal aortic aneurysm, AAA) or thoracic aorta (thoracic aortic aneurysm, TAA). Risk factors include advanced age, male sex, smoking, hypertension, atherosclerosis, and genetic connective tissue disorders such as Marfan or Loeys-Dietz syndrome. Asymptomatic in early stages, it may present with back or chest pain, pulsatile mass, or life-threatening rupture—a medical emergency with mortality exceeding 80% if untreated. Diagnosis relies on imaging modalities including contrast-enhanced CT angiography (CTA), MRI, and transthoracic or transesophageal echocardiography. Management depends on size, growth rate, and symptoms: surveillance for small, stable aneurysms; elective repair—either open surgical graft replacement or endovascular aneurysm repair (EVAR/TEVAR)—for larger or rapidly expanding lesions.

China offers distinct advantages for international patients seeking aortic aneurysm treatment. Its cardiovascular centers—many accredited by JCI or ISO—house internationally trained vascular surgeons and interventional cardiologists with extensive experience in complex aortic pathology. Advanced platforms such as robotic-assisted EVAR, fenestrated/branched stent-graft systems, and real-time 3D fusion imaging are routinely deployed. Clinical outcomes align with global benchmarks: multi-center studies report 30-day mortality rates under 2% for elective EVAR and >95% procedural success in high-volume hospitals. Crucially, treatment costs in China are typically 40–60% lower than in the US or Western Europe—without compromising quality—due to streamlined healthcare financing and domestic innovation in device manufacturing. As a dedicated medical tourism agency, we facilitate seamless access: vetting top-tier hospitals, coordinating pre-arrival diagnostics, securing transparent all-inclusive pricing (covering surgery, imaging, ICU stay, and follow-up), and providing end-to-end support—from visa assistance and interpreter services to postoperative rehabilitation planning.

Treatment Options & Itemized Cost Breakdown: Aortic Aneurysm (Cardiovascular Department)

Non-Surgical / Conservative Management

*Indicated for asymptomatic, stable aneurysms <5.0 cm (thoracic) or <5.5 cm (abdominal), with no rapid growth (>0.5 cm/year) or high-risk features.*

• •Blood Pressure Control: ACEi/ARB + beta-blocker (e.g., losartan 50 mg/day + metoprolol 25–50 mg/day): $12–$24/month
• •Lipid Management: High-intensity statin (e.g., atorvastatin 40 mg/day): $8–$16/month
• •Monitoring Protocol:

- *Biannual abdominal ultrasound (for AAA)*: $45–$65/session - *Annual echocardiography (for TAA)*: $75–$110 - *Labs (CBC, renal panel, lipid profile)*: $35–$55/year

Surgical / Interventional Options

*Eligibility requires confirmed aneurysm ≥5.0 cm (TAA) or ≥5.5 cm (AAA), symptomatic presentation, or growth >0.5 cm/6 months.*

Endovascular Aneurysm Repair (EVAR/TEVAR)

• •*Preoperative workup*: CECT (aorta + runoff), pulmonary function test, coronary CTA (if CAD risk): $520–$780
• •*Procedure cost (including stent-graft, anesthesia, ICU 1 day, 4-day hospital stay)*: $14,200–$22,800
• •*Stent-graft device cost (domestic vs. imported)*: $6,800–$15,500

• •*Preoperative workup (same as above)*: $520–$780
• •*Procedure cost (including aortic graft, cardiopulmonary bypass if TAA, ICU 2 days, 7-day hospital stay)*: $18,500–$27,300

Special / Complex Condition Options

• •Fusiform/Dissecting Aneurysm (Type A): Requires urgent OSR + ascending aorta replacement ± aortic valve: $24,900–$33,600
• •Juxtarenal/Pararenal AAA (EVAR-ineligible): Fenestrated/branched EVAR (f/B-EVAR): $31,400–$45,200 (includes custom graft: $18,000–$32,000)
• •Ruptured Aneurysm (Emergency): OSR or salvage EVAR + blood transfusion + prolonged ICU: $29,700–$48,500

Quick Selection Guide

• •<65 years, fit, TAA ≥5.5 cm or symptomatic: *Open repair* — superior long-term durability ($18,500–$27,300)
• •≥70 years, comorbidities (COPD, CKD), AAA ≥5.5 cm: *EVAR* — lower perioperative risk ($14,200–$22,800)
• •Budget-constrained, stable AAA 4.5–5.4 cm: *Conservative management + strict surveillance* ($420–$670/year)
• •Rupture or acute dissection: *Immediate OSR* — non-negotiable; cost secondary to survival ($29,700–$48,500)
• •Anatomic complexity (juxtarenal, visceral involvement): *f/B-EVAR* — only option for minimally invasive repair ($31,400–$45,200)